British American Tobacco

BAT confident about 2026

09/12/25 -"The FY2025 preliminary results were broadly in line with expectations. New categories revenue accelerated in H2, driven by oral nicotine pouches and improvements in the US vapour market with ..."

PDF page sample
Pages
51
Language
English
Published on
09/12/25
Download
You may also be interested by these reports :
17/12/25
We have updated our model to incorporate the company’s FY26/27E expectations, which continue to highlight challenges in the sugar market. As a ...
16/12/25
Danone (REDUCE ; France), a global leader in the Food -Diversified sector, is well placed to capitalise on the growing move toward healthier diets, ...
11/12/25
An opinion piece in the 10-12-2025 FT, Weight-loss drugs are bringing a new commercial reality, is making a convincing case that Food & Beverages ...
09/12/25
The FY2025 preliminary results were broadly in line with expectations. New categories revenue accelerated in H2, driven by oral nicotine pouches and ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO